Quantifying the treatment goals of people recently diagnosed with schizophrenia using best–worst scaling

References

• DeLisiLEThe concept of progressive brain change in schizophrenia: implications for understanding schizophreniaSchizophr Bull200834231232118263882
   PubMed Web of Science ®Google Scholar
• SwainSPBehuraSSDashMKNayakAKPatilSSThe influence of psychosocial dysfunctions in chronic schizophrenia patients in remission: a hospital-based studyIndian J Psychol Med201739215716328515552
   PubMedGoogle Scholar
• VosTBarberRMBellBGlobal Burden of Disease Study 2013 CollaboratorsGlobal, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the global burden of disease study 2013Lancet2015386999574380026063472
   PubMed Web of Science ®Google Scholar
• WittchenHUJacobiFRehmJThe size and burden of mental disorders and other disorders of the brain in Europe 2010Eur Neuropsychopharmacol201121965567921896369
   PubMed Web of Science ®Google Scholar
• ChongHYTeohSLWuDBKotirumSChiouCFChayakunaprukNGlobal economic burden of schizophrenia: a systematic reviewNeuropsychiatr Dis Treat20161235737326937191
   PubMed Web of Science ®Google Scholar
• BarbatoASchizophrenia and Public HealthGenevaWorld Health Organization1998
   Google Scholar
• PenningtonMMcCronePThe cost of relapse in schizophreniaPharmacoeconomics Epub2017522
   Web of Science ®Google Scholar
• ShamPCMacLeanCJKendlerKSA typological model of schizophrenia based on age of onset, sex, and familial morbidityActa Psychiatr Scand19948921351418178665
   PubMed Web of Science ®Google Scholar
• NICE, 2014 [Internet]Psychosis and schizophrenia in adults: The NICE guideline on treatment and management, updated edition2014 Available from: http://www.ncbi.nlm.nih.gov/books/NBK248060/pdf/Bookshelf_NBK248060.pdfAccessed July 10, 2017
   Google Scholar
• HasanAFalkaiPWobrockTWorld Federation of Societies of Biological Psychiatry (WFSBP) Task Force on Treatment Guidelines for SchizophreniaWorld federation of societies of biological psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistanceWorld J Biol Psychiatry201213531837822834451
   PubMed Web of Science ®Google Scholar
• KimEBerwaertsJTurkozIGopalSTime to schizophrenia relapse in relapse prevention studies of antipsychotics developed for administration daily, once monthly or every three monthsAust NZ J Psychiat201650Suppl 1166
   Google Scholar
• DecuypereFSermonJGeertsPTreatment continuation of four long-acting antipsychotic medications in the Netherlands and Belgium: a retrospective database studyPLoS One2017126e017904928614404
   PubMed Web of Science ®Google Scholar
• OchoaSLópez-CarrileroREarly psychological interventions for psychosisWorld J Psychiatry20155436236526740927
   PubMedGoogle Scholar
• MoritzSHünscheALincolnTMNonadherence to antipsychotics: the role of positive attitudes towards positive symptomsEur Neuropsychopharmacol201424111745175225444234
   PubMed Web of Science ®Google Scholar
• TaylorDMSparshattAO’HaganMDzahiniOPaliperidone palmitate: factors predicting continuation with treatment at 2 yearsEur Neuropsychopharmacol201626122011201727743760
   PubMed Web of Science ®Google Scholar
• ReddyKSThirthalliJKumarCNTreatment discontinuation in schizophrenia: a qualitative exploration from a rural South Indian communityJ Neurosci Rural Pract20178225426028479802
   PubMedGoogle Scholar
• StanghelliniGBoltonDFulfordWKMPerson-centered psychopathology of schizophrenia: building on Karl Jaspers’ Understanding of patient’s attitude toward his illnessSchizophr Bull201339228729423314193
   PubMed Web of Science ®Google Scholar
• LincolnCMcGorryPDPathways to care in early psychosis: clinical and consumer perspectivesMcGorryPDJacksonHJThe Recognition and Management of Early Psychosis: A Preventive ApproachCambridge, UKCambridge University Press20045180
   Google Scholar
• KarsonCDuffyRAEramoANylanderAGOffordSJLong-term outcomes of antipsychotic treatment in patients with first-episode schizophrenia: a systematic reviewNeuropsychiatr Dis Treat201612576726792993
   PubMed Web of Science ®Google Scholar
• DeeganPECarpenter-SongEDrakeRENaslundJALucianoAHutchisonSLEnhancing clients’ communication regarding goals for using psychiatric medicationsPsychiatr Serv201768877177528366118
   PubMed Web of Science ®Google Scholar
• VrbovaKPraskoJOciskovaMQuality of life, self-stigma, and hope in schizophrenia spectrum disorders: across-sectional studyNeuropsychiatr Dis Treat20171356757628260904
   PubMed Web of Science ®Google Scholar
• ForrayCBullerRChallenges and opportunities for the development of new antipsychotic drugsBiochem Pharmacol2017143102428522405
   PubMed Web of Science ®Google Scholar
• KinterETSchmedingARudolphIdosReisSBridgesJIdentifying patient-relevant endpoints among individuals with schizophrenia: an application of patient centered HTAInt J Tech Assess Health Care20092513541
   PubMed Web of Science ®Google Scholar
• LevitanBMarkowitzMMohamedAFPatients’ preferences related to benefits, risks, and formulations of schizophrenia treatmentPsychiatr Serv201566771972625772762
   PubMed Web of Science ®Google Scholar
• BridgesJFSlawikLSchmedingAReimerJNaberDKuhnigkOA test of concordance between patient and psychiatrist valuations of multiple treatment goals for schizophreniaHealth Expect201316216417621668795
   PubMed Web of Science ®Google Scholar
• EiringØLandmarkBFAasESalkeldGNylennaMNytrøenKWhat matters to patients? A systematic review of preferences for medication-associated outcomes in mental disordersBMJ Open201554e007848
   Web of Science ®Google Scholar
• SvenssonACLichtensteinPSandinSÖbergSSullivanPFHultmanCMFamilial aggregation of schizophrenia: the moderating effect of age at onset, parental immigration, paternal age and season of birthScand J Public Health2012401435021930618
   PubMed Web of Science ®Google Scholar
• LouviereJFlynnTNMarleyAAJBest-Worst Scaling: Theory, Methods, and ApplicationsCambridge, UKCambridge University Press2015
   Google Scholar
• BeusterienKChanESuchPDevelopment of a stated-preference instrument to prioritize treatment goals in recent onset schizophreniaCurr Med Res Opin201733122129213628945106
   PubMed Web of Science ®Google Scholar
• BeusterienKKennellyMJBridgesJFAmosKWilliamsMJVasavadaSUse of best-worst scaling to assess patient perceptions of treatments for refractory overactive bladderNeurourol Urodyn20163581028103326370222
   PubMed Web of Science ®Google Scholar
• Brett HauberAFairchildAOReed JohnsonFQuantifying benefit-risk preferences for medical interventions: an overview of a growing empirical literatureAppl Health Econ Health Policy201311431932923637054
   PubMedGoogle Scholar
• HauberABGonzálezJMGroothuis-OudshoornCGStatistical methods for the analysis of discrete choice experiments: a report of the ISPOR Conjoint Analysis Good Research Practices Task ForceValue Health201619430031527325321
   PubMed Web of Science ®Google Scholar
• DziakJJCoffmanDLLanzaSTLiRSensitivity and specificity of information criteriaPeerJ20153e135026528412
   PubMed Web of Science ®Google Scholar
• MuhlbacherACKaczynskiAZweifelPJohnsonFRExperimental measurement of preferences in health and healthcare using best-worst scaling: an overviewHealth Econ Rev201661226743636
   PubMed Web of Science ®Google Scholar
• KatzEGHauberBGopalSPhysician and patient benefit-risk preferences from two randomized long-acting injectable antipsychotic trialsPatient Prefer Adherence2016102127213927799749
   PubMed Web of Science ®Google Scholar
• CaroliFRaymondetPIzardIPlasJGallBDelgadoAOpinions of French patients with schizophrenia regarding injectable medicationPatient Prefer Adherence2011516517121573047
   PubMed Web of Science ®Google Scholar
• RosenheckRStroupSKeefeRSMeasuring outcome priorities and preferences in people with schizophreniaBr J Psychiatry200518752953616319405
   PubMed Web of Science ®Google Scholar
• ZipurskyRBCunninghamCEStewartBRimasHColeEVazSMCharacterizing outcome preferences in patients with psychotic disorders: a discrete choice experimentSchizophr Res20171875107113
   Web of Science ®Google Scholar